
ICL Group Ltd ICL
$ 4.97
-2.07%
Annual report 2024
added 12-06-2025
ICL Group Ltd Deferred Revenue 2011-2025 | ICL
Deferred revenue is the amount of money or obligations that a company has received in advance for goods or services that have not yet been delivered or performed. In other words, it is income that has already been received but has not yet been recognized in accounting as revenue because the goods or services have not yet been transferred to the customer.Features of the metric
- Sources of future cash inflows
A high level of deferred revenue indicates that the company has secured future cash flows, which positively affects forecasts of its financial condition and stability. - Assessment of operational stability
Deferred revenue reflects demand for the company’s products or services and its ability to attract customers willing to pay in advance. It is one of the indicators of business stability and its competitive advantages. - Risks and obligations
Although deferred revenue indicates future inflows, it also represents obligations that the company must fulfill. If fulfilling these obligations is delayed or impossible, it can negatively impact reputation and financial results. - Analysis of liquidity and cash flow
Inflows in the form of deferred revenue improve the company’s current liquidity since the funds are already in the accounts. However, investors need to assess the ratio of deferred revenue to fulfilled obligations to understand the actual financial capabilities and risks. - Impact on company valuation
In fundamental analysis, deferred revenue is taken into account for accurate revenue and profit forecasting, especially in industries with long-term contracts or subscriptions (e.g., IT sector, services, manufacturing).
Annual Deferred Revenue ICL Group Ltd
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 17 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17 M | 17 M | 17 M |
Deferred Revenue of other stocks in the Agricultural inputs industry
| Issuer | Deferred Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Акрон
AKRN
|
1.94 B | - | - | - | ||
|
Bioceres Crop Solutions Corp.
BIOX
|
2.87 M | $ 1.56 | -0.64 % | $ 435 M | ||
|
ФосАгро
PHOR
|
13 B | - | - | - | ||
|
China Green Agriculture
CGA
|
7.34 M | - | 0.51 % | $ 27.6 M | ||
|
CF Industries Holdings
CF
|
149 M | $ 78.57 | -0.81 % | $ 14.2 B | ||
|
FMC Corporation
FMC
|
454 M | $ 13.09 | -5.86 % | $ 1.64 B | ||
|
Corteva
CTVA
|
3.29 B | $ 65.62 | -0.68 % | $ 45.5 B | ||
|
American Vanguard Corporation
AVD
|
6.83 M | $ 4.05 | -6.14 % | $ 114 M | ||
|
Nutrien Ltd.
NTR
|
1.8 B | $ 61.9 | -1.57 % | $ 34.8 B | ||
|
Intrepid Potash
IPI
|
800 K | $ 26.77 | -1.29 % | $ 345 M | ||
|
Marrone Bio Innovations
MBII
|
360 K | - | -5.9 % | $ 180 M | ||
|
The Mosaic Company
MOS
|
271 M | $ 24.95 | -4.84 % | $ 7.98 B | ||
|
Yield10 Bioscience
YTEN
|
277 K | - | 15.32 % | $ 46.6 M | ||
|
Arcadia Biosciences
RKDA
|
8 K | $ 3.7 | 1.65 % | $ 4.58 M | ||
|
Origin Agritech Limited
SEED
|
7 M | $ 1.32 | -8.33 % | $ 7.42 M | ||
|
CVR Partners, LP
UAN
|
50.8 M | $ 95.49 | 0.14 % | $ 1.01 B |